Sintilimab plus FOLFIRINOX may provide benefits in metastatic pancreatic cancer Presented ByDr Qihan Fu, Zhejiang University School of Medicine, China TrialPhase 3, CISPD3 ConferenceASCO GI 2022 TypePeer-reviewed article 21 March 2022 12:43